ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting FSCN1 to Block the MAPK Signaling Pathway

Jia, Yiming; Li, Jingru; Wang, Jinfeng; Luo, Tianjiao; Jing, Xiaoqian; Zhao, Hongmin*哈尔滨医科大学; 1
Analytical Cellular Pathology-Cellular Oncology2022-5-13DOI: 10.1155/2022/1732365
6阅读
引用收藏
分享

摘要

Ovarian cancer (OC) is the leading cause of death for women diagnosed with gynecological cancer. Studies have shown that dysregulated miRNA expression is related to various cancers, including OC. Here, we aimed to explore the biological function and mechanism of miR-585-3p in the occurrence and development of OC. The expression level of miR-585-3p was found to be low in OC tissues and cells. We analyzed the biological function of miR-585-3p in OC through in vitro cell experiments. The results indicated that overexpression of miR-585-3p inhibited the proliferation, invasion, and migration of SW626 cells, while low expression of miR-585-3p had the opposite effect in SKOV3 cells. We then screened the target genes of miR-585-3p through miRDB database and detected the expression of target genes in OC cells. FSCN1 was found to be most significantly upregulated in OC cells. Dual-luciferase reporter assays revealed FSCN1 as a potential target of miR-585-3p. Western blot analysis showed that miR-585-3p targeted FSCN1 to inhibit protein phosphorylation of ERK. In vivo animal experiments also confirmed that miR-585-3p targets FSCN1 to inhibit tumor growth and block the MAPK signaling pathway. In summary, miR-585-3p inhibits the proliferation, migration, and invasion of OC cells by targeting FSCN1, and its mechanism of action may be achieved by inhibiting the activation of the MAPK signaling pathway. miR-585-3p may serve as a potential biomarker and therapeutic target for OC.

学科与关键词

关键词
FASCIN EXPRESSIONTUMOR-SUPPRESSORLUNG-CANCERCARCINOMAMIGRATIONINVASIONSTATISTICSTHERAPYSTRESSGROWTH
相关
加载中…
  • miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer
    Cao, Shujun; Li, Na; Liao, Xihong*Journal of Ovarian Research, 2021, 14(1): 23.被引 7
  • MicroRNA-409-5p inhibits cell proliferation, and induces G2/M phase arrest and apoptosis by targeting DLGAP5 in ovarian cancer cells
    Li, Weiwei; Lin, Ji; Huang, Jianfen; Chen, Zhuoying; Sheng, Qunying; Yang, Fang; Yang, Xue; Cui, Xiaojie*Oncology Letters, 2022, 24(2): 261.被引 2
  • Downregulation of Foxo3 and TRIM31 by miR-551b in side population promotes cell proliferation, invasion, and drug resistance of ovarian cancer
    Wei, Zhentong; Liu, Yan; Wang, Yishu; Zhang, Yandong; Luo, Qinghua; Man, Xiaxia; Wei, Feng*; Yu, Xiaowei*MEDICAL ONCOLOGY, 2016, 33(11): 126.被引 38
查看全部 →

发表信息

论文状态
公开发表
期刊
Analytical Cellular Pathology-Cellular Oncology
发表日期
2022-05-13
卷期
第 2022 卷
页码
1732365
DOI
10.1155/2022/1732365
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Foundation of the First Affiliated Hospital of Harbin Medical University [2010M10]

作者

  • J

    Jia, Yiming (第一作者)

    1 · harbin med univ

  • L

    Li, Jingru

    1 · harbin med univ

查看全部 6 位作者收起作者
  • W

    Wang, Jinfeng

    1 · harbin med univ

  • L

    Luo, Tianjiao

    1 · harbin med univ

  • J

    Jing, Xiaoqian

    1 · harbin med univ

  • Z

    Zhao, Hongmin (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417